His primary scientific interests are in Huntington's disease, Disease, Neuroscience, Internal medicine and Pathology. Raymund A.C. Roos interconnects Chorea, Atrophy, Age of onset, Physical therapy and Depression in the investigation of issues within Huntington's disease. His work deals with themes such as Psychological intervention, Psychiatry, Clinical psychology, Coping and Pediatrics, which intersect with Disease.
His research investigates the connection between Neuroscience and topics such as Parkinson's disease that intersect with issues in Posturography, Dopaminergic, Cog, Balance and Neurological disorder. His studies in Internal medicine integrate themes in fields like Sleep in non-human animals, Endocrinology, Oncology and Trinucleotide repeat expansion. His Endocrinology research is multidisciplinary, incorporating perspectives in Huntingtin and Orexin.
His main research concerns Huntington's disease, Disease, Internal medicine, Neuroscience and Pathology. The concepts of his Huntington's disease study are interwoven with issues in Physical medicine and rehabilitation, Psychiatry, Cognition, Clinical psychology and Atrophy. In his study, which falls under the umbrella issue of Physical medicine and rehabilitation, Physical therapy is strongly linked to Parkinson's disease.
His study focuses on the intersection of Cognition and fields such as Audiology with connections in the field of Developmental psychology. His Disease study which covers Trinucleotide repeat expansion that intersects with Huntingtin. His biological study spans a wide range of topics, including Endocrinology, Depression, Oncology and Cardiology.
Raymund A.C. Roos spends much of his time researching Huntington's disease, Disease, Cognition, Internal medicine and Atrophy. His Huntington's disease research is multidisciplinary, incorporating elements of White matter, Physical medicine and rehabilitation, Rating scale, Neurodegeneration and Neuroscience. His Disease research includes themes of Analysis of variance and Clinical psychology.
His Cognition study combines topics from a wide range of disciplines, such as Visual perception and Audiology. His work carried out in the field of Internal medicine brings together such families of science as Endocrinology, Oncology and Cardiology. Raymund A.C. Roos has researched Atrophy in several fields, including Sample size determination, Putamen, Neuroimaging, Allele and Brain size.
Raymund A.C. Roos mainly investigates Huntington's disease, Disease, Cognition, Atrophy and Neuroscience. His Huntington's disease research incorporates elements of White matter, Audiology, Electroencephalography, Neurodegeneration and Putamen. His Disease study is related to the wider topic of Internal medicine.
The various areas that Raymund A.C. Roos examines in his Cognition study include Receiver operating characteristic, Clinical psychology and Age of onset. His study in Atrophy is interdisciplinary in nature, drawing from both Depression, Sample size determination and Brain size. Hypokinesia, Caudate nucleus, Basal ganglia, Chorea and Functional imaging is closely connected to Grey matter in his research, which is encompassed under the umbrella topic of Neuroscience.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi;Douglas R Langbehn;Blair R Leavitt;Raymund A C Roos.
Lancet Neurology (2009)
Huntington's disease: a clinical review
Raymund A C Roos.
Orphanet Journal of Rare Diseases (2010)
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
Sarah J Tabrizi;Rachael I Scahill;Gail N Owen;Alexandra Durr.
Lancet Neurology (2013)
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
Sarah J Tabrizi;Rachael I Scahill;Alexandra Durr;Raymund A C Roos.
Lancet Neurology (2011)
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
Kirupa Sathasivam;Andreas Neueder;Theresa A. Gipson;Christian Landles.
Proceedings of the National Academy of Sciences of the United States of America (2013)
Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease
Bastiaan R. Bloem;Bastiaan R. Bloem;Dennis J. Beckley;J. Gert van Dijk;Aeilko H. Zwinderman.
Movement Disorders (1996)
Orexin loss in Huntington's disease
Åsa Petersén;Joana Gil;Marion L.C. Maat-Schieman;Maria Björkqvist.
Human Molecular Genetics (2005)
Characterization and localization of the Huntington disease gene product
André T. Hoogeveen;Rob Willemsen;Nicolle Meyer;Karien E.de Roolj.
Human Molecular Genetics (1993)
Prevalence of subjective dysphagia in community residents aged over 87.
B R Bloem;A M Lagaay;W van Beek;J Haan.
Atrophy of the Hypothalamic Lateral Tuberal Nucleus in Huntington's Disease
H. P. H. Kremer;R. A. C. Roos;G. Dingjan;E. Marani.
Journal of Neuropathology and Experimental Neurology (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: